Retraction: Endogenous control of cell cycle progression by autocrine transforming growth factor β in breast cancer cells (Cancer Research (2004) 64 (2509-2515) DOI: 10.1158/0008-5472.CAN-03-2654);Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor β in Breast Cancer Cells

Cancer Research

Volumn 64, Issue 7, 2004, Pages 2509-2515

  Ammanamanchi, Sudhakar ^a   Tillekeratne, Manoranjani P M ^b   Ko, Tien C ^c   Brattain, Michael G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 2; ESTROGEN RECEPTOR; HISTONE H1; NEUTRALIZING ANTIBODY; PROTAMINE KINASE; TETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER GROWTH; CELL CYCLE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STEADY STATE;

EID: 1942442226     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-19-0071     Document Type: Erratum

References (30)

1. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
2. Wrana JL, Attisano L, Carcamo J, et al. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-14.
3. Lyons RM, Moses HL. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 1990;187:467-73.
4. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol 1990;6: 597-641.
5. Spom MB, Roberts A. TGF-β: recent progress and new challenges. J Cell Biol 1992;119:1017-21.
6. Morgan DO. Cyclin-dependent kinases: engines, clocks and microprocessors. Ann Rev Cell Dev Biol 1997;13:261-91.
7. Koff A, Cross F, Fisher A, et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 1991;66:1217-28.
8. Ohtsubo M, Roberts JM. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 1993;259:1908-12.
9. Resnitzky D, Hengst L, Reed SI. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27kip1. Mol Cell Biol 1995;15:4347-52.
10. Vidal A, Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene 2000;247:1-15.
11. Park K, Kim, S-J, Bang YJ, et al. Genetic changes in the TGF-β type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 1994;91:8772-6.
12. Sun L-Z, Wu G, Willson JKV, et al. Expression of TGF-β type II receptor leads to reduced malignancy in human breast cancer MCF-7L cells. J Biol Chem 1994;269: 26449-55.
13. + colon carcinoma cells. J Biol Chem 1995;270:22044-9.
14. Wang J, Han W, Zborowska E, et al. Reduced expression of TGF-β type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 1996; 271:17366-71.
15. Kang SH, Bang YJ, Im YH, et al. Transcriptional repression of TGF-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer. Oncogene 1999;18:7280-6.
16. + breast cancer cells through Sp1 activation by 5 aza-2′dc. J Biol Chem 1998;273:16527-34.
17. Geng Y, Weinberg RA. TGF-β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 1993;90:10315-9.
18. Ewen M, Sluss HK, Whitehouse LL, Livingston DM. TGF-β inhibition of CDK4 synthesis is linked to cell cycle arrest. Cell 1993;74:1009-20.
19. Feng XH, Filvaroff EH, Derynck R. TGF-β induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J Biol Chem 1995;270: 24237-45.
20. Ko TC, Sheng HM, Reisman D, Thompson AE, Beauchamp DR. TGF-β inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 1995;10:177-84.
21. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 1993; 260:536-9.
22. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang, X-F. TGF-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995;92:5545-9.
23. Peter M, Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994;79:181-4.
24. Moustakas A, Kardassis D. Regulation of the human p21/WAF1/CIP1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 1998;95:6733-8.
25. Hu PP, Shen X, Huang D, Liu Y, Counter C, Wang XF. The MEK pathway is required for stimulation of p21/WAF1/CIP1 by TGF-β. J Biol Chem 1999;274:35381-7.
26. Ahmed MM, Alcock RA, Chendil., D., et al. Restoration of TGF-b signaling enhances radiosensitivity by altering the Bcl2/Bax ratio in the P53 mutant pancreatic cancer cell line MIA PaCa-2. J Biol Chem 2002;277:2234-46.
27. Gong JG, Ammanamanchi S, Ko TC, Brattain MG. TGF-β1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res 2003;63:3340-6.
28. Wu SP, Theodorescu D, Kerbel R, et al. TGF-β1 is an autocrine negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 1992;116:186-97.
29. Wu SP, Sun, L-Z, Willson JKV, Fields K, Humphrey LE, Brattain MG. Repression of autocrine TGF-β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Diff 1993;4:115-23.
30. Apprelikova O, Xiong Y, Liu ET. Both p16 and p21 families ofCDK inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK- activating kinase. J Biol Chem 1995;270:18195-7.